Essential Pharmaceuticals has served the transplant community with its products, service and contributions to transplant medicine since 2006. Custodiol HTK was initially launched in 2000, but brought into the folds of Essential Pharmaceuticals in 2006. Since 2006, Essential has grown into a significant, highly specialized business with a distinct sales, customer service and marketing team.
Custodiol HTK has grown to be one of the leading organ preservation solutions in the United States. Under the terms of the agreement, along with the Essential company, Accord has acquired the rights to sell Custodiol HTK Solution (www.custodiol.com) in the United States and Canada.
Custodiol HTK has grown to be one of the leading organ preservation solutions in the United States. Under the terms of the agreement, along with the Essential company, Accord has acquired the rights to sell Custodiol HTK Solution (www.custodiol.com) in the United States and Canada.
Services
Liver Transplant Biliary Complications for Deceased Donor Grafts: Comparison of HTK and UW Solutions. HTK liver graft preservation in deceased donors is associated with better graft survival, less imaging, less risk of biliary leak and intrahepatic stricture, and a lower risk of intrahepatic strictures in DCD grafts.
Reviews
Be the first to review Essential Pharmaceuticals.
Write a Review
